REFERENCES
- Al-Achi A., Boroujerdi M. Pharmacokinetics and tissue uptake of doxorubicin associated with erythrocyte-membrane: Erythrocytes-ghosts vs. erythrocytes-vesicles. Drug Devel. Ind. Pharm. 1990; 16: 2199–2219
- Babiuk S., Baca-Estrada M., Babuik L. A., Ewen C., Foldvari M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J. Control. Rel. 2000; 66: 199–214
- Banker G. S., Rhodes C. T. Modern Pharmaceutics. Marcel Dekker Inc, New York 2002
- Coombes A. G. A., Lavelle E. C., Jenkins P. G., Davis S. S. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine 1996; 14: 1429–1438
- Giudice G. D., Podda A., Rappuoli R. What are the limits of adjuvanticity?. Vaccine 2002; 20: S38–S41
- Gupta R. K., Siber G. R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 1995; 13: 1263–1276
- Gutierrez Millan C., Zarzuelo Castaneda A., Sayalero Marinero M. L., Lanao J. M. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood Cells Mol. Dis. 2004a; 33: 132–140
- Gutierrez Millan C., Sayalero Marinero M. L., Zarzuelo Castaneda A., Lanao J. M. Drug, enzyme and peptide delivery using erythrocytes as carriers. J. Control. Rel. 2004b; 95: 27–49
- Hamidi M., Tajerzadeh H. Carrier erythrocytes: an overview. Drug Del. 2003; 10: 9–20
- Highley M. S., De Bruijn E. A. Erythrocytes and the transport of drugs and endogenous compounds. Pharm. Res. 1996; 13: 186–195
- Hoshi S., Saito N., Kusanagi K., Ihara T., Ueda S. Adjuvant effects of fluoride on oral immunization of chickens. Vet. Immunol. Immunopathol. 1998; 63: 253–263
- Jain S., Jain S. K., Dixit V. K. Magnetically guided rat erythrocytes bearing isoniazid: preparation, characterization, and evaluation. Drug Devel. Ind. Pharm. 1997; 23: 999–1006
- Jaitely V., Kanaujia P., Venkatesan N., Jain S., Vyas S. P. Resealed erythrocytes: drug carrier potentials and biomedical applications. Ind. Drugs. 1996; 33: 589–549
- Magnani M., Rossi L., Fraternale A., Bianchi M., Antonelli A., Crinelli R., Chiarantini L. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Ther. 2002; 9: 749–751
- O'Hagan D. T., Singh M., Gupta R. K. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv. Drug Deliv. Rev. 1998; 32: 225–246
- Powell M. F. Drug delivery issues in vaccine development. Pharm. Res. 1996; 13: 1777–1785
- Ramaldes G. A., Deverre J.-R., Grognet J.-M., Puisieux F., Fattal E. Use of an enzyme immunoassay for the evaluation of entrapment efficiency and in vitro stability in intestinal fluids of liposomal bovine serum albumin. Int. J. Pharm. 1996; 143: 1–11
- Rossi L., Brandi G., Schiavano G. F., Balestra E., Millo E., Scarfi S., Damonte G., Gasparini A., Magnani M., Perno C. F., Benatti V., De Flora A. Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir. AIDS Res. Hum. Retroviruses. 1998; 14: 435–444
- Rossi L., Serafini S., Pierige F., Antonelli A., Cerasi A., Fraternale A., Chiarantini L., Magnani M. Erythrocyte-based drug delivery. Expert Opin. Drug Del. 2005; 2: 311–322
- Sprott G. D., Tolson D. L., Patel G. B. Archaeosomes as novel antigen delivery systems. FEMS Microbiol. Lett. 1997; 154: 17–22
- Storni T., Kundig T. M., Senti G., Johansen P. Immunity in response to particulate antigen-delivery systems. Adv. Drug Del. Rev. 2005; 57: 333–355
- Summers M. P. Recent advances in drug delivery. Pharm. J. 1983; 230: 643–645
- Tajerzadeh H., Hamidi M. Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes. Drug Dev. Ind. Pharm. 2000; 26: 1247–1257
- Talwar N., Jain N. K. Erythrocytes as carrier of primaquin preparation: characterization and evaluation. J. Control. Rel. 1992; 20: 133–142
- Zhao Z., Leong K. W. Controlled delivery of antigens and adjuvants in vaccine development. J. Pharm. Sci. 1996; 85: 1261–1270
- Zhou S., Liao X., Li X., Deng X., Li H. Poly-D, L-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems. J. Control. Rel. 2003; 86: 195–205